H. Codrington

发表

Influence of the Acidic Beverage Cola on the Absorption of Erlotinib in Patients With Non-Small-Cell Lung Cancer.

J. Aerts, B. van der Holt, C. H. van der Leest, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab.

J. Aerts, E. Dieleman, M. Verheij, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Is 18F-FDG PET/CT Useful for the Early Prediction of Histopathologic Response to Neoadjuvant Erlotinib in Patients with Non–Small Cell Lung Cancer?

H. Klomp, H. van Tinteren, R. V. Valdés Olmos, 2010, The Journal of Nuclear Medicine.

Is 18 F-FDG PET/CT Useful for the Early Prediction of Histopathologic Response to Neoadjuvant Erlotinib in Patients with Non – Small Cell Lung Cancer?

H. Klomp, H. Tinteren, H. Codrington, 2010 .

Lung Cancer : Targets and Therapy Practical management of NSCLC patients with long-term bevacizumab treatment : a report of four cases

J. Aerts, H. Codrington, G. Herder, 2013 .

Practical management of NSCLC patients with long-term bevacizumab treatment: a report of four cases.

J. Aerts, H. Codrington, G. Herder, 2013, Lung Cancer.

Unusual pulmonary lesions: case 2. Endobronchial carcinoid of the lung.

T. Sutedja, P. Postmus, J. V. van Mourik, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Activity of single-agent gemcitabine as second-line treatment after previous chemotherapy or radiotherapy in advanced non-small-cell lung cancer.

H. Groen, N. Aaronson, M. Muller, 2001, Lung cancer.

A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study.

O. Dalesio, H. Groen, E. Smit, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[Breast cancer in the early stage].

R. J. Jones, M. Espié, G. Giaccone, 2012, Gan no rinsho. Japan journal of cancer clinics.

Real-life safety of PD-1 and PD-L1 inhibitors in older patients with cancer: An observational study.

H. Codrington, P. Brocken, L. Visser, 2022, Journal of geriatric oncology.

Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy.

H. Codrington, H. Sleeboom, L. W. Wormhoudt, 2008, European journal of cancer.

A randomized, multicenter phase II study investigating additional weekly cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: Reporting on the efficacy.

J. Aerts, E. Dieleman, M. Verheij, 2012 .

OC-0498 CONCURRENT CHEMORADIOTHERAPY WITH OR WITHOUT CETUXIMAB IN NSCLC; TOXICITY RESULTS OF A RANDOMIZED PHASE II TRIAL

J. Aerts, E. Dieleman, M. Verheij, 2012 .

The Effect of A Geriatric Assessment on Treatment Decisions for Patients with Lung Cancer

J. Lammers, H. Codrington, L. V. van Elden, 2017, Lung.

Tumor response and toxicity of neoadjuvant erlotinib in patients with early-stage non-small-cell lung cancer.

H. Klomp, J. Burgers, H. van Tinteren, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigating.

J. Aerts, E. Dieleman, M. Verheij, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Prospective cohort study of patients with advanced cancer and their relatives on the experienced quality of care and life (eQuiPe study): a study protocol

M. Pepels, L. van Zuylen, C. Pitz, 2020, BMC Palliative Care.

18F-Fluorodeoxyglucose Positron Emission Tomography versus Computed Tomography in Predicting Histopathological Response to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor Treatment in Resectable Non-Small Cell Lung Cancer

H. Klomp, H. van Tinteren, H. Rijna, 2014, Annals of Surgical Oncology.

A text-mining approach to study the real-world effectiveness and potentially fatal immune-related adverse events of PD-1 and PD-L1 inhibitors in older patients with stage III/IV non-small cell lung cancer

E. Smit, J. Zwaveling, H. Codrington, 2023, BMC Cancer.

Autofluorescence bronchoscopy improves staging of radiographically occult lung cancer and has an impact on therapeutic strategy.

T. Sutedja, P. Postmus, J. V. van Mourik, 2001, Chest.

Real-life safety of PD-1 and PD-L1 inhibitors in older patients with cancer: An observational study.

H. Codrington, P. Brocken, L. Visser, 2021, Journal of geriatric oncology.

Prognostic Value of Geriatric 8 and Identification of Seniors at Risk for Hospitalized Patients Screening Tools for Patients With Lung Cancer

J. Lammers, H. Codrington, L. V. van Elden, 2017, Clinical lung cancer.

Practical management of NSCLC patients with long-term bevacizumab treatment: a report of four cases.

H. Codrington, G. Herder, C. Colder, 2013, Lung Cancer.

Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy.

H. Codrington, H. Sleeboom, L. W. Wormhoudt, 2008, European journal of cancer.

Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigating.

J. Aerts, E. Dieleman, M. Verheij, 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.